Literature DB >> 16624841

Interaction of homocysteine and conventional predisposing factors on risk of ischaemic stroke in young people: consistency in phenotype-disease analysis and genotype-disease analysis.

A Pezzini1, M Grassi, E Del Zotto, D Assanelli, S Archetti, R Negrini, L Caimi, A Padovani.   

Abstract

BACKGROUND AND OBJECTIVES: Whether the association between mild hyperhomocysteinaemia and ischaemic stroke is the consequence of a predisposing genetic background or is due to the confounding influence of established predisposing factors remains to be determined.
METHODS: Plasma total homocysteine (tHcy) concentration and the distribution of the C677T genotypes of the methylenetetrahydrofolate reductase gene (MTHFR) were compared in 174 consecutive patients with stroke aged <45 years and 155 age and sex-matched controls. The effect of conventional risk factors on the relationship between phenotype-disease and genotype-disease was analysed by two-way and three-way interaction analysis and by the classification and regression trees (CART) model.
RESULTS: tHcy concentrations were markedly higher in patients with ischaemic stroke (median 11.9 micromol/l, range 2.0-94.0) than in controls (median 9.8 micromol/l, range 4.7-49.6). An increased risk was also associated with the TT677 genotype (odds ratio (OR) 1.98; 95% confidence interval (CI) 1.04 to 3.78) and with the T allele (1.40; 95% 1.03 to 1.92) of the MTHFR gene. A differential effect of Hcy levels on risk of stroke was observed according to the distribution of environmental-behavioural risk factors, with a stronger influence in the subcategory of people with hypertension and smokers (OR 24.8; 95% CI 3.15 to 196). A comparable environmental-dependent TT677 MTHFR genotype-stroke association was observed in the genotype-disease analysis.
CONCLUSIONS: A consistency of phenotype-disease analysis and genotype-disease analysis is indicated by analysing specific subcategories of patients, defined by the distribution of established risk factors. The assumption that the Hcy-stroke relationship is unlikely due to a reverse-causality bias is indirectly supported by our data.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16624841      PMCID: PMC2077547          DOI: 10.1136/jnnp.2005.076083

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  24 in total

1.  MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

Authors:  Mariska Klerk; Petra Verhoef; Robert Clarke; Henk J Blom; Frans J Kok; Evert G Schouten
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

2.  Fractions of total plasma homocysteine in patients with ischemic stroke before the age of 55 years.

Authors:  Anna B Sobol; Edward Bald; Jerzy Loba
Journal:  Angiology       Date:  2005 Mar-Apr       Impact factor: 3.619

3.  Planning genetic studies in human stroke: sample size estimates based on family history data.

Authors:  Ahamad Hassan; Pak C Sham; Hugh S Markus
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

Review 4.  Homocysteine and cardiovascular disease: cause or effect?

Authors:  L Brattström; D E Wilcken
Journal:  Am J Clin Nutr       Date:  2000-08       Impact factor: 7.045

Review 5.  The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke.

Authors: 
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

Review 6.  Genetics and ischaemic stroke.

Authors:  A Hassan; H S Markus
Journal:  Brain       Date:  2000-09       Impact factor: 13.501

7.  Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke.

Authors:  Alessandro Pezzini; Elisabetta Del Zotto; Silvana Archetti; Riccardo Negrini; Paolo Bani; Alberto Albertini; Mario Grassi; Deodato Assanelli; Roberto Gasparotti; Luigi Amedeo Vignolo; Mauro Magoni; Alessandro Padovani
Journal:  Stroke       Date:  2002-03       Impact factor: 7.914

8.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

Authors:  David S Wald; Malcolm Law; Joan K Morris
Journal:  BMJ       Date:  2002-11-23

9.  Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults.

Authors:  Nigel Choon-Kiat Tan; N Venketasubramanian; Seang-Mei Saw; Helen Tjoei-Lian Tjia
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

10.  Homocysteine, MTHFR 677C-->T polymorphism, and risk of ischemic stroke: results of a meta-analysis.

Authors:  P J Kelly; J Rosand; J P Kistler; V E Shih; S Silveira; A Plomaritoglou; K L Furie
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

View more
  5 in total

1.  MTHFR 677 TT genotype and hyperhomocysteinaemia: an underestimated risk TANDEM for patients with stroke.

Authors:  V Caso; M Paciaroni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06-16       Impact factor: 10.154

2.  Genetic determinants of intracranial large artery stenosis in the northern Manhattan study.

Authors:  Minghua Liu; Sanjeev Sariya; Farid Khasiyev; Giuseppe Tosto; Nicole D Dueker; Ying Kuen Cheung; Clinton B Wright; Ralph L Sacco; Tatjana Rundek; Mitchell S V Elkind; Jose Gutierrez
Journal:  J Neurol Sci       Date:  2022-03-03       Impact factor: 4.553

3.  The combination of homozygous MTHFR 677T and angiotensin II type-1 receptor 1166C variants confers the risk of small-vessel-associated ischemic stroke.

Authors:  Zoltan Szolnoki; Anita Maasz; Lili Magyari; Katalin Horvatovich; Bernadett Farago; Ferenc Somogyvari; Andras Kondacs; Mihaly Szabo; Anita Bodor; Ferenc Hadarits; Bela Melegh
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

4.  Prevalence and risk factors for hyperhomocysteinemia: a population-based cross-sectional study from Hunan, China.

Authors:  Yide Yang; Yuan Zeng; Shuqian Yuan; Ming Xie; Yanhui Dong; Jian Li; Quanyuan He; Xiangli Ye; Yuan Lv; Carl-Friedrich Hocher; Bernhard K Kraemer; Xiuqin Hong; Berthold Hocher
Journal:  BMJ Open       Date:  2021-12-06       Impact factor: 2.692

Review 5.  Relationship of Methylenetetrahydrofolate Reductase (MTHFR) C677T Variation With Susceptibility of Patients With Ischemic Stroke: A Meta-Analysis.

Authors:  Pramod Kumar; Aparna Mishra; Manoj K Prasad; Vivek Verma; Amit Kumar
Journal:  Cureus       Date:  2022-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.